Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A dermatomyositis characterized by the presence of anti-MDA5 autoantibodies. It is often associated with dermatomyositis rashes, amyopathic or hypomyopathic muscle involvement and interstitial lung disease, frequently as a rapid progressive course and high mortality.
Biomarker and diagnostic research for anti-MDA5 dermatomyositis has been reported in the published literature.
1 clinical trial registered, 1 recruiting. Interventions under study include drug therapy and biologic therapy. Pipeline includes 1 NA. Research is primarily sponsored by academic and government institutions.
150 publications have been identified in PubMed for anti-MDA5 dermatomyositis. Research spans Case Report / Case Series (30%), Epidemiology / Natural History (25%), and Basic Science / Preclinical (19%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 45 |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 11:12 AM UTC
Disease patterns and progression | 38 | 25% |
Laboratory research | 29 | 19% |
Testing and diagnosis research | 16 | 11% |
Research summaries | 10 | 7% |
Clinical study results | 9 | 6% |
New treatment approaches | 3 | 2% |
Zhang Q (2026). [PMID: 42099655](https://pubmed.ncbi.nlm.nih.gov/42099655/). *Front Immunol*. [Review / Meta-Analysis]
Zhang C (2026). [PMID: 41522073](https://pubmed.ncbi.nlm.nih.gov/41522073/). *Quant Imaging Med Surg*. [Diagnostic / Biomarker]
Zhang M (2026). [PMID: 41580740](https://pubmed.ncbi.nlm.nih.gov/41580740/). *Arthritis Res Ther*. [Basic Science / Preclinical]
Chen Z (2026). [PMID: 41680864](https://pubmed.ncbi.nlm.nih.gov/41680864/). *Respiratory research*. [Epidemiology / Natural History]
Ahmed D (2026). [PMID: 41699840](https://pubmed.ncbi.nlm.nih.gov/41699840/). *The American journal of case reports*. [Case Report / Case Series]
Van Gompel E (2026). [PMID: 41719605](https://pubmed.ncbi.nlm.nih.gov/41719605/). *J Autoimmun*. [Basic Science / Preclinical]
He W (2026). [PMID: 40679080](https://pubmed.ncbi.nlm.nih.gov/40679080/). *Journal of the European Academy of Dermatology and Venereology : JEADV*. [Epidemiology / Natural History]
Matsuo H (2026). [PMID: 41711173](https://pubmed.ncbi.nlm.nih.gov/41711173/). *ACR open rheumatology*. [Diagnostic / Biomarker]
Chang A (2026). [PMID: 41984803](https://pubmed.ncbi.nlm.nih.gov/41984803/). *Rheumatology (Oxford)*. [Epidemiology / Natural History]
Mogyoróssy S (2026). [PMID: 41898353](https://pubmed.ncbi.nlm.nih.gov/41898353/). *Biomedicines*. [Epidemiology / Natural History]